Search results for "1506"

showing 10 items of 235 documents

Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomized, double blind, placebo controlled, phase III study.

2015

Objective To assess the efficacy of recombinant human erythropoietin (rhEPO) in amyotrophic lateral sclerosis (ALS). Methods Patients with probable laboratory-supported, probable or definite ALS were enrolled by 25 Italian centres and randomly assigned (1:1) to receive intravenous rhEPO 40 000 IU or placebo fortnightly as add-on treatment to riluzole 100 mg daily for 12 months. The primary composite outcome was survival, tracheotomy or >23 h non-invasive ventilation (NIV). Secondary outcomes were ALSFRS-R, slow vital capacity (sVC) and quality of life (ALSAQ-40) decline. Tolerability was evaluated analysing adverse events (AEs) causing withdrawal. The randomisation sequence was computer-…

MaleGastroenterologylaw.inventionRandomized controlled triallaw1506Amyotrophic lateral sclerosisMOTOR NEURON DISEASEeducation.field_of_studyRecombinant ProteinMiddle AgedRecombinant ProteinsTreatment OutcomePsychiatry and Mental HealthNeuromuscularSettore MED/26 - NeurologiaFemaleerythropoietyn clinical trialmedicine.drugHumanALS; MOTOR NEURON DISEASE; Adult; Aged; Amyotrophic Lateral Sclerosis; Double-Blind Method; Erythropoietin; Female; Humans; Male; Middle Aged; Recombinant Proteins; Treatment OutcomeAdultmedicine.medical_specialtyPopulationSocio-culturalePlaceboDouble blindALS; erythropoietyn clinical trialDouble-Blind MethodArts and Humanities (miscellaneous)ALS; MOTOR NEURON DISEASE; Adult; Aged; Amyotrophic Lateral Sclerosis; Double-Blind Method; Epoetin Alfa; Erythropoietin; Female; Humans; Male; Middle Aged; Recombinant Proteins; Treatment Outcome; Neurology (clinical); Psychiatry and Mental Health; Surgery; Arts and Humanities (miscellaneous)Internal medicinemedicineALS; MOTOR NEURON DISEASEHumanseducationErythropoietinAgedbusiness.industryAmyotrophic Lateral SclerosisEpoetin alfamedicine.diseaseSurgeryClinical trialEpoetin AlfaErythropoietinSurgeryNeurology (clinical)ALSbusinessAmyotrophic Lateral Sclerosi
researchProduct

Students' satisfaction and perceived impact on knowledge, attitudes and skills after a 2-day course in scientific writing: a prospective longitudinal…

2018

OBJECTIVES: This study aimed to determine students' satisfaction with a 2-day course on scientific writing in health sciences and to assess their perceptions of the long-term impact on their knowledge, attitudes and skills. SETTING: 27 iterations of a 2-day course on writing and publishing scientific articles in health sciences. PARTICIPANTS: 741 students attending the 27 courses. DESIGN: Prospective longitudinal study. PRIMARY AND SECONDARY OUTCOME MEASURES: Immediately after each course, students completed a first questionnaire, rating their satisfaction with different aspects of the classroom sessions on a Likert scale (0-5). Approximately 2 years after the course, students completed a f…

MaleHealth Knowledge Attitudes PracticeLongitudinal studyBiomedical ResearchWriting17090302 clinical medicineSecondary outcomeSurveys and QuestionnairespublishingMedicineLongitudinal Studies1506030212 general & internal medicineCiències de la salut1354030504 nursingGeneral MedicineMiddle AgedResearch PersonnelPublishingobservationl studyFemaleCurriculum0305 other medical scienceAdultScienceeducationEstudiants universitarisMedical sciencesCourse (navigation)Likert scale03 medical and health sciencesEducation ProfessionalScientific writingHumansCollege studentsStudentsCurriculumMedical educationbusiness.industryResearchEscrits científics i tècnics -- Redacció -- EnsenyamentConsumer BehaviorMedical Education and TrainingWriting skillsSpainjournalologybusiness
researchProduct

Retirement age and type as predictors of frailty : a retrospective cohort study of older businessmen

2020

ObjectivesTo study the association between retirement characteristics and frailty in a homogenous population of former business executives.DesignCross-sectional cohort study using data from the Helsinki Businessmen Study.SettingHelsinki, Finland.Participants1324 Caucasian men, born in 1919–1934, who had worked as business executives and managers and of whom 95.9% had retired by the year 2000. Questions on age at and type of retirement, lifestyle and chronic conditions were embedded in questionnaires.Primary and secondary outcome measuresFrailty assessed according to a modified phenotype definition at mean age 73.3 years.ResultsMean age at retirement was 61.3 years (SD 4.3) and 37.1% had ret…

MaleIMPACToccupational & industrial medicineCohort Studies0302 clinical medicineEpidemiologyMedicineEMPLOYMENT1506030212 general & internal medicineSTATE PENSION AGEHEALTH EVIDENCEkohorttitutkimusFinlandAged 80 and overGeriatricsRISKRetirementeducation.field_of_studyFrailtyindustrial medicinepublic healthRMENGeneral MedicineMiddle AgedWORKINGMedicineeläkeikäepidemiologyoccupational &amp1716ikääntyneetMIDLIFECohort studymedicine.medical_specialtyFrail ElderlyPopulation03 medical and health sciencesHumanseducationAgedRetrospective StudiesOccupational and Environmental Medicinebusiness.industrygeriatric medicinePublic healthMORTALITYRetrospective cohort studyCross-Sectional StudiesikääntyminenAgeing3121 General medicine internal medicine and other clinical medicineeläkkeelle siirtyminenTRAJECTORIESbusiness030217 neurology & neurosurgeryRetirement agehauraus-raihnausoireyhtymäDemography
researchProduct

Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study.

2019

ObjectivesBimatoprost–timolol (bimatoprost 0.03%–timolol 0.5% fixed-dose combination [FDC]) and tafluprost–timolol (tafluprost 0.0015%–timolol 0.5% FDC) eye drops are currently the only topical intraocular pressure (IOP)-reducing therapies available as preservative-free (PF) prostaglandin and timolol FDC. The aim of this study was to investigate changes to ocular signs and symptoms when patients with ocular hypertension (OH) or open-angle glaucoma (OAG) switched from PF or benzalkonium chloride (BAK)-preserved bimatoprost–timolol to PF tafluprost–timolol eye drops.DesignThis was a 12-week, open-label, phase IV study.SettingSixteen centres in Finland, Germany, Italy and the UK.ParticipantsPa…

MaleIntraocular pressuregenetic structuresOcular hypertensionGlaucomaTimololBenzalkonium chloride0302 clinical medicine1506clinical pharmacology; clinical trials; glaucoma; intraocular pressure; medical ophthalmology; ocular surface; Medicine (all)Aged 80 and overintegumentary systemMedicine (all)General MedicineMiddle AgedIntention to Treat AnalysisDrug Combinations030220 oncology & carcinogenesisTimololFemaleGlaucoma Open-Anglemedicine.drug1718Adultmedicine.medical_specialtyDrug Administration Schedule03 medical and health sciencesOphthalmologymedicineHumansAntihypertensive AgentsIntraocular PressureAgedclinical trialsocular surfaceBimatoprostbusiness.industryResearchPreservatives PharmaceuticalProstaglandins FTafluprostmedicine.diseaseeye diseasesmedical ophthalmologyClinical trialOphthalmologyBimatoprostglaucoma030221 ophthalmology & optometryQuality of LifeOcular Hypertensionsense organsclinical pharmacologyOphthalmic SolutionsbusinessBMJ open
researchProduct

High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemia

2013

Background and purpose Clinical scores are recommended for predicting cardiovascular risk in patients with cerebral ischaemia to inform secondary prevention. Blood biomarkers may improve prediction beyond clinical scores. Methods Within the observational Find-AF trial (ISRCTN46104198), 197 patients >18 years of age with cerebral ischaemia and without atrial fibrillation had blood sampled at baseline. The predictive value of five biomarkers for a combined vascular endpoint (acute coronary syndrome, stroke, cardiovascular death) and all-cause mortality was determined, alone and in addition to the Essen Stroke Risk Score (ESRS), Stroke Prognostic Instrument 2 (SPI-2) and National Institutes of…

MaleKaplan-Meier Estimate030204 cardiovascular system & hematologyBrain IschemiaCohort Studies0302 clinical medicineNatriuretic Peptide BrainMedicine1506Prospective StudiesProspective cohort studyStrokeTroponin TAtrial fibrillationMiddle AgedPrognosisTroponin3. Good healthStrokePsychiatry and Mental healthCardiovascular DiseasesIschemic Attack TransientPredictive value of testsCardiologyFemaleFatty Acid Binding Protein 3Atrial Natriuretic Factormedicine.medical_specialtyAcute coronary syndromeGrowth Differentiation Factor 15Endpoint DeterminationCardiologyFatty Acid-Binding ProteinsRisk Assessment03 medical and health sciencesTroponin TPredictive Value of TestsInternal medicineHumansSurvival analysisAgedbusiness.industryProportional hazards modelmedicine.diseaseSurvival AnalysisPeptide FragmentsSurgeryCerebrovascular DiseaseSurgeryNeurology (clinical)businessBiomarkers030217 neurology & neurosurgeryFollow-Up StudiesJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

International Physical Activity and Built Environment Study of Adolescents : IPEN Adolescent design, protocol and measures

2021

IntroductionOnly international studies can provide the full variability of built environments and accurately estimate effect sizes of relations between contrasting environments and health-related outcomes. The aims of the International Physical Activity and Environment Study of Adolescents (IPEN Adolescent) are to estimate the strength, shape and generalisability of associations of the community environment (geographic information systems (GIS)-based and self-reported) with physical activity and sedentary behaviour (accelerometer-measured and self-reported) and weight status (normal/overweight/obese).Methods and analysisThe IPEN Adolescent observational, cross-sectional, multicountry study …

MaleNEIGHBORHOOD ENVIRONMENTstatistics & research methodsWalkingOverweightCardiovascularOral and gastrointestinal0302 clinical medicineresearch methodsBelgiumResidence CharacteristicsInformed assentResearch MethodsMedicine and Health SciencesMedicineSOCIOECONOMIC-STATUS030212 general & internal medicine1506IsraelBuilt EnvironmentAetiologyChildBuilt environmentCzech RepublicCancerPediatricBangladeshpublic healthSEDENTARY BEHAVIORGeneral MedicineStrokeYOUTHWalkabilityRELIABILITYPublic Health and Health ServicesHong KongFemaleepidemiologySCHOOL-AGED CHILDRENHEALTHPSYCHOSOCIAL FACTORSmedicine.symptomsocial and economic factorsBrazilPediatric Research InitiativeAdolescentInternational studiesClinical SciencesNigeriaIndiapreventive medicine03 medical and health sciencesYoung Adult2.3 PsychologicalEnvironmental healthHumansObesitySocioeconomic statusExerciseMetabolic and endocrineNutritionOBJECTIVE ASSESSMENTWALKABILITY SCALEOther Medical and Health SciencesPortugalbusiness.industry1730PreventionMalaysiaAustralia030229 sport sciencesCross-Sectional StudiesSpainSurvey data collectionObservational studyEnvironment Designstatistics &ampbusinessNew Zealand
researchProduct

An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubici…

2016

Objectives The objective of this study was to explore the association between health-related quality of life (HRQoL) and the recommended phase 2 dose in a phase I clinical trial according to the Time to HRQoL deterioration approach (TTD). Setting This is a phase I dose-escalation trial of transarterial chemoembolisation (TACE) with idarubicin-loaded beads performed in cirrhotic patients with hepatocellular carcinoma. Patients had to complete the EORTC QLQ-C30 HRQoL questionnaire at baseline and at days 15, 30 and 60 after TACE. Participants Patients aged ≥18 years with HCC unsuitable for curative treatments were evaluated for the study (N=21). Primary and secondary outcome measurements The …

MaleOncologyHealth-related Quality of LifePhases of clinical research[ SDV.CAN ] Life Sciences [q-bio]/Cancer0302 clinical medicineQuality of life1506FatigueAntibiotics AntineoplasticLiver NeoplasmsGeneral MedicineMiddle Aged3. Good healthOncology030220 oncology & carcinogenesisHepatocellular carcinomaToxicityFemale[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology030211 gastroenterology & hepatology1717medicine.drugmedicine.medical_specialtyCarcinoma HepatocellularMaximum Tolerated Dose1722Pain[SDV.CAN]Life Sciences [q-bio]/CancerPhase 1Disease-Free Survival03 medical and health sciencesInternal medicineCarcinomamedicineHumansIdarubicinChemoembolization TherapeuticAgedHealth-related Quality of ifeOncology clinical trialHealth related quality of lifebusiness.industryResearchlongitudinal analysis[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterologyphase Imedicine.diseaseSurgeryTime to deteriorationMaximum tolerated doseQuality of LifeIdarubicinbusinessBMJ Open
researchProduct

Social support as a mediator between problem behaviour and gambling: a cross-sectional study among 14–16-year-old Finnish adolescents

2016

Background: During the adolescent period, risktaking behaviour increases. These behaviours can compromise the successful transition from adolescence to adulthood. The purpose of this study was to examine social support as a mediator of the relation between problem behaviour and gambling frequency among Finnish adolescents. Methods: Data were obtained from the national School Health Promotion Study (SHPS) from the years 2010 and 2011 (N=102 545). Adolescents were classified in the most homogeneous groups based on their problem behaviour via latent class analysis.Results: Path analysis indicated that social support was negatively associated with problem behaviour, and problem behaviour and so…

MaleParentsmedicine.medical_specialtyAdolescentCross-sectional studyKansanterveystiede ympäristö ja työterveys - Public health care science environmental and occupational healthCompromisemedia_common.quotation_subjectPsychological intervention030508 substance abuseAddictionsosiaalinen tukiFriendsriskikäyttäytyminen1681Developmental psychology03 medical and health sciencesSocial supportRisk-TakingMedicine1724Humans0501 psychology and cognitive sciences1506adolescentsPath analysis (statistics)StudentsFinlandmedia_commonProblem BehaviorSchoolsbusiness.industryPublic healthAddictionResearch05 social sciencesSocial SupportGeneral MedicineLatent class modelgamblingongelmakäyttäytyminenCross-Sectional StudiesAdolescent BehaviorGamblingFemalePUBLIC HEALTH0305 other medical sciencebusiness050104 developmental & child psychology
researchProduct

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants

2012

Abstract: Background Two recent studies identified a mutation (p.Asp620Asn) in the vacuolar protein sorting 35 gene as a cause for an autosomal dominant form of Parkinson disease. Although additional missense variants were described, their pathogenic role yet remains inconclusive. Methods and results We performed the largest multi-center study to ascertain the frequency and pathogenicity of the reported vacuolar protein sorting 35 gene variants in more than 15,000 individuals worldwide. p.Asp620Asn was detected in 5 familial and 2 sporadic PD cases and not in healthy controls, p.Leu774Met in 6 cases and 1 control, p.Gly51Ser in 3 cases and 2 controls. Overall analyses did not reveal any sig…

MaleParkinson's diseasePopulationVesicular Transport ProteinsLocus (genetics)DiseaseBiologyVPS35 protein humanBioinformaticsgenetics [Vesicular Transport Proteins]genetics [Parkinson Disease]Risk Factorsmedicinemetabolism [Vesicular Transport Proteins]GeneticsMissense mutationVPS35 GeneHumansGenetic epidemiologyGenetic Predisposition to Diseaseddc:6101506Genome-wideeducationGenetics (clinical)Genetic Association StudiesGeneticsVacuolar protein sortingeducation.field_of_studyGenotype-Phenotype CorrelationsParkinson DiseaseComplex traitsmedicine.diseasePenetranceddc:MutationFemaleHuman medicineParkinson-s diseaseJournal of Medical Genetics
researchProduct

ROC-king onwards: intraepithelial lymphocyte counts, distribution & role in coeliac disease mucosal interpretation

2017

ObjectivesCounting intraepithelial lymphocytes (IEL) is central to the histological diagnosis of coeliac disease (CD), but no definitive ‘normal’ IEL range has ever been published. In this multicentre study, receiver operating characteristic (ROC) curve analysis was used to determine the optimal cut-off between normal and CD (Marsh III lesion) duodenal mucosa, based on IEL counts on >400 mucosal biopsy specimens.DesignThe study was designed at the International Meeting on Digestive Pathology, Bucharest 2015. Investigators from 19 centres, eight countries of three continents, recruited 198 patients with Marsh III histology and 203 controls and used one agreed protocol to count IEL/100 ent…

MalePathologySettore MED/09 - Medicina Interna2312ROC-curve analysiBiopsyCoeliac diseaseSerology0302 clinical medicineintraepithelial lymphocytesDiagnosis80 and overROC-curve analysis; coeliac disease; intraepithelial lymphocytes1506LymphocytesIntestinal MucosaChild1507medicine.diagnostic_testArea under the curveGastroenterologyhemic and immune systemsMiddle AgedPrognosis030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemalemedicine.symptomtissuesAdultmedicine.medical_specialtyAdolescentchemical and pharmacologic phenomenaBiologydigestive systemLesion03 medical and health sciencesBiopsymedicineHumansLymphocyte CountPreschoolAgedReceiver operating characteristicInfantHistologymedicine.diseaseNewbornROC-curve analysis; coeliac disease; intraepithelial lymphocytes; Adolescent; Adult; Aged; Aged 80 and over; Biopsy; Case-Control Studies; Celiac Disease; Child; Child Preschool; Diagnosis Differential; Female; Humans; Infant; Infant Newborn; Intestinal Mucosa; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Prognosis; ROC Curve; GastroenterologyCeliac DiseaseROC CurveCase-Control StudiesDifferentialIntraepithelial lymphocyteROC-curve analysiscoeliac disease
researchProduct